as on November 8, 2025 at 2:29 am IST
Day's Low
Day's High
8.21%
Downside
-0.09%
Upside
52 Week's Low
52 Week's High
65.09%
Downside
33.13%
Upside
Check Eyepoint Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$915.5M
EPS (TTM)
-3.1175
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-216.2M
Revenue (TTM)
42.3M
Profit Margin
0.00%
Return On Equity TTM
-98.23%
Compare market cap, revenue, PE, and other key metrics of Eyepoint Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $915.5M | 201.1% | NA | 0.00% | |
| BUY | $40.5B | 482.44% | -16.34 | -264.83% | |
| BUY | $58.2B | 238.64% | 1420.94 | 1.36% | |
| BUY | $105.6B | 85.89% | 29.33 | 31.35% | |
| BUY | $68.0B | 13.75% | 15.51 | 32.13% |
The Eyepoint Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Eyepoint Pharmaceuticals Inc investment value today
Current value as on today
₹1,01,450
Returns
₹1,450
(+1.45%)
Returns from Eyepoint Pharmaceuticals Inc Stock
Dollar Returns*
₹5,147 (+5.15%)
Based on 16 analysts
93.75%
Buy
6.25%
Hold
0.00%
Sell
Based on 16 analysts, 93.75% of analysts recommend a 'BUY' rating for Eyepoint Pharmaceuticals Inc. Average target price of $34.42
Get share price movements and forecasts by analysts on Eyepoint Pharmaceuticals Inc.
What analysts predicted
67.46%UPSIDE
Target Price
$34.42
Current Price
$11.2
Analyzed by
16 Analysts
Target
$34.42
Eyepoint Pharmaceuticals Inc target price $34.42, a slight upside of 67.46% compared to current price of $11.2. According to 16 analysts rating.
Search interest for Eyepoint Pharmaceuticals Inc Stock has increased by 63% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:63% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 897.2% return, outperforming this stock by 790.9%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 152.5% return, outperforming this stock by 157.2%
Revenue Fall
![]()
Revenue is down for the last 3 quarters, 24.45M → 966.0K (in $), with an average decrease of 80.0% per quarter
Profit Down
![]()
Netprofit is down for the last 5 quarters, -29.36M → -59.73M (in $), with an average decrease of 20.5% per quarter
Price Dip
![]()
In the last 7 days, EYPT stock has moved down by -15.4%
| Organisation | Eyepoint Pharmaceuticals Inc |
| Headquarters | 480 Pleasant Street, Watertown, MA, United States, 02472 |
| Industry | Health Technology |
| CEO | Dr. Jay S. Duker M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Ron I. Honig Esq. | Chief Legal Officer & Company Secretary |
Ms. Jennifer Leonard | Chief People Officer & Senior VP of IT |
Ms. Isabelle Lefebvre | Chief Regulatory Officer |
Mr. Michael J. Maciocio | Chief Manufacturing Officer |
Dr. Anna Kluczewska | CEO of AION Diagnostics Ltd, President of AION Diagnostics Ltd and Director of AION Diagnostics Ltd |
Dr. Jay S. Duker M.D. | President, CEO & Director |
Dr. Ramiro Ribeiro M.D., Ph.D. | Chief Medical Officer |
Mr. David Scott Jones M.A. | Senior VP & Chief Commercial Officer |
Mr. George O. Elston CPA | Executive VP & CFO |
Dr. Marcia Sellos-Moura Ph.D. | Chief Scientific Officer |
Eyepoint Pharmaceuticals Inc share price today is $11.2 as on at the close of the market. Eyepoint Pharmaceuticals Inc share today touched a day high of $11.19 and a low of $10.28.
Eyepoint Pharmaceuticals Inc share touched a 52 week high of $14.91 on and a 52 week low of $3.91 on . Eyepoint Pharmaceuticals Inc stock price today i.e. is closed at $11.2,which is 24.88% down from its 52 week high and 186.45% up from its 52 week low.
Eyepoint Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Eyepoint Pharmaceuticals Inc (EYPT) shares with as little as ₹88.66 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.60 in Eyepoint Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Eyepoint Pharmaceuticals Inc share’s latest price of $11.2 as on November 8, 2025 at 2:29 am IST, you will get 0.8929 shares of Eyepoint Pharmaceuticals Inc. Learn more about
fractional shares .
Eyepoint Pharmaceuticals Inc stock has given 201.1% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?